- Home
- LEDS vs EVAX Comparison
LEDS vs EVAX Comparison
Compare LEDS & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- EVAX
- Stock Information
- Founded
- LEDS 2005
- EVAX 2008
- Country
- LEDS Taiwan
- EVAX Denmark
- Employees
- LEDS N/A
- EVAX N/A
- Industry
- LEDS Semiconductors
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LEDS Technology
- EVAX Health Care
- Exchange
- LEDS Nasdaq
- EVAX Nasdaq
- Market Cap
- LEDS 16.1M
- EVAX 17.8M
- IPO Year
- LEDS 2010
- EVAX 2021
- Fundamental
- Price
- LEDS $2.48
- EVAX $5.71
- Analyst Decision
- LEDS
- EVAX Strong Buy
- Analyst Count
- LEDS 0
- EVAX 2
- Target Price
- LEDS N/A
- EVAX $13.50
- AVG Volume (30 Days)
- LEDS 36.0K
- EVAX 4.8M
- Earning Date
- LEDS 11-26-2025
- EVAX 11-07-2025
- Dividend Yield
- LEDS N/A
- EVAX N/A
- EPS Growth
- LEDS N/A
- EVAX N/A
- EPS
- LEDS N/A
- EVAX N/A
- Revenue
- LEDS $31,108,000.00
- EVAX $3,176,000.00
- Revenue This Year
- LEDS N/A
- EVAX N/A
- Revenue Next Year
- LEDS N/A
- EVAX $425.50
- P/E Ratio
- LEDS N/A
- EVAX N/A
- Revenue Growth
- LEDS 485.62
- EVAX 1042.45
- 52 Week Low
- LEDS $1.09
- EVAX $1.20
- 52 Week High
- LEDS $3.16
- EVAX $15.50
- Technical
- Relative Strength Index (RSI)
- LEDS 57.25
- EVAX 49.79
- Support Level
- LEDS $2.26
- EVAX $5.29
- Resistance Level
- LEDS $2.76
- EVAX $12.15
- Average True Range (ATR)
- LEDS 0.21
- EVAX 1.46
- MACD
- LEDS -0.00
- EVAX -0.24
- Stochastic Oscillator
- LEDS 62.16
- EVAX 6.05
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.